The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 74.
413. lappuse
... evidence to support his allega- tions if the Examiner questions the utility alleged . When the Exam- iner requests such proof , evidence on standard test animals may suf- fice.106 If the allegations relate only to humans , clinical evidence ...
... evidence to support his allega- tions if the Examiner questions the utility alleged . When the Exam- iner requests such proof , evidence on standard test animals may suf- fice.106 If the allegations relate only to humans , clinical evidence ...
499. lappuse
... evidence . Two points should be especially noted , first the provisions of Rule 285 that require waiver of many points of objection unless seasonably made , and second the provision of Rule 286 that the rules of evidence will be applied ...
... evidence . Two points should be especially noted , first the provisions of Rule 285 that require waiver of many points of objection unless seasonably made , and second the provision of Rule 286 that the rules of evidence will be applied ...
693. lappuse
... evidence which had been submitted as being insufficient . The Board of Appeals , in reversing the Examiner , relied upon the Bergel and Krimmel decisions , supra , stating that these decisions , handed down since the date of the Ex ...
... evidence which had been submitted as being insufficient . The Board of Appeals , in reversing the Examiner , relied upon the Bergel and Krimmel decisions , supra , stating that these decisions , handed down since the date of the Ex ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention